Weil Company, Inc. Amicus Therapeutics, Inc. Transaction History

Weil Company, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$9.2 - $23.86 $99,727 - $258,642	-10,840 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$13.47 - $24.89 $33,675 - $62,225	-2,500 Reduced 18.74%	10,840 $250,000
Q3 2020 Nov 12, 2020	BUY	$12.89 - $15.89 $10,827 - $13,347	840 Added 6.72%	13,340 $188,000
Q2 2020 Aug 13, 2020	BUY	$8.86 - $15.69 $22,150 - $39,225	2,500 Added 25.0%	12,500 $189,000
Q2 2019 Aug 12, 2019	BUY	$10.96 - $14.4 $109,600 - $144,000	10,000 New	10,000 $125,000

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.71B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Weil Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Weil Company, Inc. with notifications on news.